Cell Source, Inc.: 10-Q filed 2022-12-08
What Cell Source, Inc. reported in its quarterly report filed 2022-12-08 (fiscal Q3 2022): 22 published measures, 74 facts as tagged in accession 0001493152-22-034876.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2022-12-08
- Fiscal period
- fiscal Q3 2022
- Accession
- 0001493152-22-034876 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Cell Source, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-09-30 | 360,611 | USD | |
| At 2021-12-31 | 313,767 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-09-30 | 12,314,581 | USD | |
| At 2021-12-31 | 10,139,902 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-09-30 | -11,953,970 | USD | |
| At 2022-06-30 | -10,766,559 | USD | |
| At 2022-03-31 | -9,997,117 | USD | |
| At 2021-12-31 | -9,826,135 | USD | |
| At 2021-09-30 | -10,187,899 | USD | |
| At 2021-06-30 | -10,026,910 | USD | |
| At 2021-03-31 | -9,038,794 | USD | |
| At 2020-12-31 | -7,947,382 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-09-30 | 65,940 | USD | |
| At 2021-12-31 | 93,095 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-07-01 to 2022-09-30 | -1,252,306 | USD | 92 |
| 2022-01-01 to 2022-09-30 | -3,830,475 | USD | 273 |
| 2022-04-01 to 2022-06-30 | -1,285,594 | USD | 91 |
| 2022-01-01 to 2022-03-31 | -1,292,575 | USD | 90 |
| 2021-07-01 to 2021-09-30 | -1,799,568 | USD | 92 |
| 2021-01-01 to 2021-09-30 | -4,637,422 | USD | 273 |
| 2021-04-01 to 2021-06-30 | -1,313,113 | USD | 91 |
| 2021-01-01 to 2021-03-31 | -1,524,741 | USD | 90 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-01-01 to 2022-09-30 | -2,415,411 | USD | 273 |
| 2021-01-01 to 2021-09-30 | -2,919,478 | USD | 273 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-01-01 to 2022-09-30 | 2,388,256 | USD | 273 |
| 2021-01-01 to 2021-09-30 | 3,273,813 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-09-30 | -35,008,903 | USD | |
| At 2021-12-31 | -31,178,428 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-07-01 to 2022-09-30 | 35,240,745 | shares | 92 |
| 2022-01-01 to 2022-09-30 | 34,696,011 | shares | 273 |
| 2021-07-01 to 2021-09-30 | 33,461,141 | shares | 92 |
| 2021-01-01 to 2021-09-30 | 32,897,010 | shares | 273 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-07-01 to 2022-09-30 | -0.04 | USD/shares | 92 |
| 2022-01-01 to 2022-09-30 | -0.14 | USD/shares | 273 |
| 2021-07-01 to 2021-09-30 | -0.06 | USD/shares | 92 |
| 2021-01-01 to 2021-09-30 | -0.16 | USD/shares | 273 |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-07-01 to 2022-09-30 | 74,756 | USD | 92 |
| 2022-01-01 to 2022-09-30 | 79,790 | USD | 273 |
| 2021-07-01 to 2021-09-30 | 140,528 | USD | 92 |
| 2021-01-01 to 2021-09-30 | 424,272 | USD | 273 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-07-01 to 2022-09-30 | -1,016,043 | USD | 92 |
| 2022-01-01 to 2022-09-30 | -3,102,592 | USD | 273 |
| 2021-07-01 to 2021-09-30 | -1,315,332 | USD | 92 |
| 2021-01-01 to 2021-09-30 | -3,431,787 | USD | 273 |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-09-30 | 674,220 | USD | |
| At 2021-12-31 | 223,041 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-07-01 to 2022-09-30 | 1,016,043 | USD | 92 |
| 2022-01-01 to 2022-09-30 | 3,102,592 | USD | 273 |
| 2021-07-01 to 2021-09-30 | 1,315,332 | USD | 92 |
| 2021-01-01 to 2021-09-30 | 3,431,787 | USD | 273 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-07-01 to 2022-09-30 | 468,005 | USD | 92 |
| 2022-01-01 to 2022-09-30 | 1,487,520 | USD | 273 |
| 2021-07-01 to 2021-09-30 | 446,773 | USD | 92 |
| 2021-01-01 to 2021-09-30 | 1,037,588 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-09-30 | 35,244,850 | shares | |
| At 2021-12-31 | 34,360,546 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-09-30 | 23,017,863 | USD | |
| At 2021-12-31 | 21,316,318 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-09-30 | 1,284,619 | USD | |
| At 2021-12-31 | 1,097,021 | USD |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-07-01 to 2022-09-30 | -1,552,133 | USD | 92 |
| 2022-01-01 to 2022-09-30 | -4,700,190 | USD | 273 |
| 2021-07-01 to 2021-09-30 | -2,045,760 | USD | 92 |
| 2021-01-01 to 2021-09-30 | -5,332,878 | USD | 273 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-07-01 to 2022-09-30 | 533,538 | USD | 92 |
| 2022-01-01 to 2022-09-30 | 1,571,572 | USD | 273 |
| 2021-07-01 to 2021-09-30 | 856,059 | USD | 92 |
| 2021-01-01 to 2021-09-30 | 2,333,724 | USD | 273 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-07-01 to 2022-09-30 | -236,263 | USD | 92 |
| 2022-01-01 to 2022-09-30 | -727,883 | USD | 273 |
| 2021-07-01 to 2021-09-30 | -484,236 | USD | 92 |
| 2021-01-01 to 2021-09-30 | -1,205,635 | USD | 273 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-01-01 to 2022-09-30 | 451,179 | USD | 273 |
| 2021-01-01 to 2021-09-30 | 92,067 | USD | 273 |
Inspect the source
- Entity
- Cell Source, Inc. / CIK 0001569340
- Captured
- 2026-09-20T09:20:59.488Z
- SEC response SHA-256
a38ee9440e4c17d7e1a60b5c62fea787c32a17056a875641a758e857a5dd95d2
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001569340.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))